Related Experiment Video
Updated: Jun 8, 2026
08:31
Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
Published on: September 12, 2025
[Molecular target drugs for malignant lymphoma]
1Department of Hematology/Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|October 20, 2010
Summary
Novel molecular therapies targeting B cell and T cell lymphomas are emerging. These include inhibitors for mTOR, IKK/JAK, HDAC, proteasome, HSP90, and proapoptotic molecules, showing promising anti-lymphoma activity.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Context:
- The revised World Health Organization classification highlights biological differences in lymphoid malignancies.
- Identifying molecular targets is crucial for advancing lymphoma treatment.
- While B cell lymphomas have established targets (e.g., CD20, CD22, CD19), T cell lymphomas require further molecular target development.
Purpose:
- To review novel molecular drugs currently under development for B cell and T cell lymphomas.
- To discuss the potential anti-lymphoma activities of these emerging therapies.
Summary:
- New molecularly targeted drugs are in clinical trials for both B cell and T cell lymphomas.
- These include inhibitors targeting mTOR, IKK/JAK, HDAC, proteasome, HSP90, and proapoptotic pathways.
- Immunomodulatory drugs like lenalidomide are also being investigated for their efficacy in lymphoma treatment.
Impact:
- These novel therapies offer promising new avenues for treating lymphomas.
- Advancements in molecular targeting could lead to more personalized and effective lymphoma treatments.
- The development of drugs for T cell lymphomas addresses an unmet clinical need.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.